Bexsero 50 μg, 25 μg Suspensions for Injection
Clinical Summary
Quick overview from the medicine insert
Indication
Active immunization against invasive disease caused by Neisseria meningitidis group B.
Dosage (summary)
Administer 2 doses of 0.5 mL each, with the second dose given at least 1 month after the first dose.
Onset of Action / Duration
Immunity develops approximately 1 month after the second dose.
Special Populations
- Immunocompromised individuals
- Individuals with a history of allergic reactions to vaccine components
Pregnancy & Breastfeeding
Safety during pregnancy and lactation has not been established; use only if clearly needed.
Key Drug Interactions
- Immunosuppressive therapies may reduce vaccine efficacy.
- Concurrent administration with other vaccines is generally acceptable.
Contraindications
- Severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine.
- Acute illness with or without fever.
Common side effects
- Injection site reactions (pain, redness, swelling)
- Fever
- Fatigue
- Headache
- Nausea
Counselling Points
- Inform patients about the importance of completing the vaccination schedule.
- Advise on potential side effects and their management.
- Encourage reporting of any severe allergic reactions.
Serious warnings
- Monitor for signs of anaphylaxis after administration.
- Vaccination may not provide complete protection against meningococcal disease.
Important Disclaimer
The Bexsero 50 μg, 25 μg Suspensions for Injection professional information leaflet below is the property of Glaxosmithkline South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
